Paper11462001
Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine.
Guirakhoo F and 11 others. J Virol, 2001. Cited by 184 papers, by iCite.
Cite this record
ConductScience Library. Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine. Papers, record 11462001. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11462001
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Dengue | Major topic |
| Dengue Virus | Major topic |
| Viral Vaccines | Major topic |
| Yellow fever virus | Major topic |
| Animals | |
| Chlorocebus aethiops | |
| Mice | |
| Reassortant Viruses | |
| Vero Cells |
Source PubMed
References52
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10074160 | Yellow fever/Japanese encephalitis chimeric viruses: construction and biological properties. | J Virol | 1999 | https://conductscience.org/library/papers/10074160 | PubMed |
| 2 | 10967284 | Dengue viral infections; pathogenesis and epidemiology. | Microbes Infect | 2000 | https://conductscience.org/library/papers/10967284 | PubMed |
| 3 | 7723688 | Studies on serological cross-reaction in sequential flavivirus infections. | Microbiol Immunol | 1994 | https://conductscience.org/library/papers/7723688 | PubMed |
| 4 | 5419208 | Observations related to pathogensis of dengue hemorrhagic fever. VI. Hypotheses and discussion. | Yale J Biol Med | 1970 | https://conductscience.org/library/papers/5419208 | PubMed |
| 5 | 10933719 | Chimeric yellow fever/dengue virus as a candidate dengue vaccine: quantitation of the dengue virus-specific CD8 T-cell response. | J Virol | 2000 | https://conductscience.org/library/papers/10933719 | PubMed |
| 6 | 10664386 | Identification of an epitope on the dengue virus membrane (M) protein defined by cross-protective monoclonal antibodies: design of an improved epitope sequence based on common determinants present in both envelope (E and M) proteins. | Arch Virol | 1999 | https://conductscience.org/library/papers/10664386 | PubMed |
| 7 | 6824120 | Original antigenic sin in dengue. | Am J Trop Med Hyg | 1983 | https://conductscience.org/library/papers/6824120 | PubMed |
| 8 | 8146129 | Dengue: the risk to developed and developing countries. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/8146129 | PubMed |
| 9 | 3277268 | Pathogenesis of dengue: challenges to molecular biology. | Science | 1988 | https://conductscience.org/library/papers/3277268 | PubMed |
| 10 | 8465377 | Use of 'original antigenic sin' theory to determine the serotypes of previous dengue infections. | Trans R Soc Trop Med Hyg | 1993 | https://conductscience.org/library/papers/8465377 | PubMed |
| 12 | 10364309 | Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E. | J Virol | 1999 | https://conductscience.org/library/papers/10364309 | PubMed |
| 13 | 10217584 | Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates. | Vaccine | 1999 | https://conductscience.org/library/papers/10217584 | PubMed |
| 14 | 4984581 | Immunologic studies with yellow fever and selected African group B arboviruses in rhesus and vervet monkeys. | Am J Trop Med Hyg | 1970 | https://conductscience.org/library/papers/4984581 | PubMed |
| 15 | 10233934 | Dengue virus structural differences that correlate with pathogenesis. | J Virol | 1999 | https://conductscience.org/library/papers/10233934 | PubMed |
| 16 | 10030052 | [Serotypes and genotypes of dengue virus circulating in Venezuela, 1990-1997]. | Acta Cient Venez | 1998 | https://conductscience.org/library/papers/10030052 | PubMed |
| 17 | 9519821 | Identification of a major determinant of mouse neurovirulence of dengue virus type 2 using stably cloned genomic-length cDNA. | J Gen Virol | 1998 | https://conductscience.org/library/papers/9519821 | PubMed |
| 18 | 10608744 | Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. | J Infect Dis | 2000 | https://conductscience.org/library/papers/10608744 | PubMed |
| 19 | 2665015 | Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade. | Rev Infect Dis | 1989 | https://conductscience.org/library/papers/2665015 | PubMed |
| 20 | 10329547 | Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis. | Virology | 1999 | https://conductscience.org/library/papers/10329547 | PubMed |
| 21 | 8447176 | Effect of immunity to the carrier protein on antibody responses to Haemophilus influenzae type b conjugate vaccines. | Vaccine | 1993 | https://conductscience.org/library/papers/8447176 | PubMed |
Cited by91
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 184 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42523811 | Targeting dengue through mucosal vaccination: the potential of NS1 and bacterial spore-based delivery platforms. | Front Immunol | 2026 | https://conductscience.org/library/papers/42523811 | PubMed |
| 42356234 | Effect of Short-Term Grape Powder Supplementation in Patients with Crohn's Disease: A Pilot Study. | Nutrients | 2026 | https://conductscience.org/library/papers/42356234 | PubMed |
| 42339734 | A secretion-deficient DENV1 DNA vaccine induces durable immunity and confers protection against DENV2. | Zool Res | 2026 | https://conductscience.org/library/papers/42339734 | PubMed |
| 41917113 | Integrative immunogenomic strategy for designing a multi-epitope vaccine against Zika and Dengue viruses. | Sci Rep | 2026 | https://conductscience.org/library/papers/41917113 | PubMed |
| 41213642 | Safety and immunogenicity of a tetravalent dengue vaccine (CYD-TDV) in HIV-positive adults aged 18-50 years in Brazil: Results from a phase II, randomized, observer-blind, placebo-controlled trial. | Hum Vaccin Immunother | 2025 | https://conductscience.org/library/papers/41213642 | PubMed |
| 40473809 | T Cell Responses During Dengue Infection. | Curr Top Microbiol Immunol | 2026 | https://conductscience.org/library/papers/40473809 | PubMed |
| 40432141 | Development of New Live-Attenuated Vaccine Candidates Lacking Antibody-Dependent Enhancement (ADE) Against Dengue. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/40432141 | PubMed |
| 40044132 | Advancements in dengue vaccines: A historical overview and pro-spects for following next-generation candidates. | J Microbiol | 2025 | https://conductscience.org/library/papers/40044132 | PubMed |
| 39861846 | Latin America's Dengue Outbreak Poses a Global Health Threat. | Viruses | 2025 | https://conductscience.org/library/papers/39861846 | PubMed |
| 39861790 | Animal Models, Therapeutics, and Vaccine Approaches to Emerging and Re-Emerging Flaviviruses. | Viruses | 2024 | https://conductscience.org/library/papers/39861790 | PubMed |
| 39700304 | Genetic diversity of dengue virus circulating in the Philippines (2014-2019) and comparison with dengue vaccine strains. | PLoS Negl Trop Dis | 2024 | https://conductscience.org/library/papers/39700304 | PubMed |
| 38543793 | Single-Dose Immunogenic DNA Vaccines Coding for Live-Attenuated Alpha- and Flaviviruses. | Viruses | 2024 | https://conductscience.org/library/papers/38543793 | PubMed |
| 38140260 | A Novel, Comprehensive A129 Mouse Model for Investigating Dengue Vaccines and Evaluating Pathogenesis. | Vaccines (Basel) | 2023 | https://conductscience.org/library/papers/38140260 | PubMed |
| 37331111 | An in vitro workflow to create and modify infectious clones using replication cycle reaction. | Virology | 2023 | https://conductscience.org/library/papers/37331111 | PubMed |
| 35835315 | A multiple-target mRNA-LNP vaccine induces protective immunity against experimental multi-serotype DENV in mice. | Virol Sin | 2022 | https://conductscience.org/library/papers/35835315 | PubMed |
| 35705721 | A canine-derived chimeric antibody with high neutralizing activity against canine parvovirus-2. | AMB Express | 2022 | https://conductscience.org/library/papers/35705721 | PubMed |
| 35608749 | Dengue Vaccines: An Update. | BioDrugs | 2022 | https://conductscience.org/library/papers/35608749 | PubMed |
| 34499320 | Vaccine-Associated Enhanced Viral Disease: Implications for Viral Vaccine Development. | BioDrugs | 2021 | https://conductscience.org/library/papers/34499320 | PubMed |
| 34209433 | Live Viral Vaccine Neurovirulence Screening: Current and Future Models. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/34209433 | PubMed |
| 34036241 | Dengvaxia: the world's first vaccine for prevention of secondary dengue. | Ther Adv Vaccines Immunother | 2021 | https://conductscience.org/library/papers/34036241 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11462001
GET https://conductscience.org/api/papers/v1/11462001/references?page=2